mefloquine has been researched along with Nervous System Disorders in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 9 (56.25) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambler, MT; Arunjerdja, R; Dubowitz, LM; Hla, EP; Luxemburger, C; McGready, R; Nosten, F; Singhasivanon, P; Thwai, KL; Viladpainguen, J | 1 |
| Chelo, D; Djoukoue, F; Frey, SG; Hatz, C; Kinkela, MN; Tietche, F; Weber, P | 1 |
| Ditters, JM; Ligthelm, RJ; Overbosch, D; Stricker, BH; Sturkenboom, MC; Tulen, JH; van Riemsdijk, MM | 1 |
| Bhattacharjee, AK; Dow, GS; Gerena, L; Hudson, TH; Koenig, ML; Lopez-Sanchez, M; Wolf, L | 1 |
| Aarnoudse, AL; Dieleman, J; Ligthelm, RJ; Molokhia, M; Overbosch, D; Stricker, BH; van der Heiden, IP; van Riemsdijk, MM; van Schaik, RH | 1 |
| Bruder, C; Jung, P; Korhonen, C; Peterson, K | 1 |
| Wright, D | 1 |
| Barrett, PJ; Bradley, DJ; Clarke, PD; Emmins, PD | 1 |
| Bethell, DB; Day, NP; Ly, VC; Mai, NT; Nguyen, TH; Tran, TH; Waller, D; White, NJ | 1 |
| Dollow, S | 1 |
| de Munter, J; Hoebe, C; Thijs, C | 1 |
| Bygbjerg, IC; Gøtzsche, PC; Rønn, AM; Rønne-Rasmussen, J | 1 |
| Jensen, JJ | 1 |
| Held, T; Mravak, S; Trautmann, M; Weinke, T | 1 |
| Fernex, M; Handschin, J; Kaiser, D; Kerr, L; Mittelholzer, ML; Reber, R; Stürchler, D | 1 |
| Campbell, CC; Patchen, LC; Williams, SB | 1 |
4 trial(s) available for mefloquine and Nervous System Disorders
| Article | Year |
|---|---|
The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Asia; Asia, Southeastern; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Nervous System Diseases; Neurologic Examination | 2009 |
Artesunate-mefloquine combination therapy in acute Plasmodium falciparum malaria in young children: a field study regarding neurological and neuropsychiatric safety.
Topics: Africa; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Mental Disorders; Nervous System Diseases; Plasmodium falciparum | 2010 |
Post-malaria neurological syndrome.
Topics: Adolescent; Adult; Antimalarials; Child; Female; Humans; Incidence; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Nervous System Diseases; Prospective Studies; Risk Factors; Syndrome; Vietnam | 1996 |
[Clinical experiences with mefloquine in tropical malaria--a prospective study].
Topics: Adolescent; Adult; Africa, Western; Animals; Female; Germany; Humans; Madagascar; Malaria; Male; Mefloquine; Mental Disorders; Nausea; Nervous System Diseases; Plasmodium falciparum; Prospective Studies; Travel; Uganda; Vomiting | 1991 |
12 other study(ies) available for mefloquine and Nervous System Disorders
| Article | Year |
|---|---|
Low body mass index is associated with an increased risk of neuropsychiatric adverse events and concentration impairment in women on mefloquine.
Topics: Adolescent; Adult; Aged; Antimalarials; Attention; Body Mass Index; Child; Cohort Studies; Female; Humans; Malaria; Mefloquine; Middle Aged; Mood Disorders; Nervous System Diseases; Prospective Studies; Risk Factors | 2004 |
The antimalarial potential of 4-quinolinecarbinolamines may be limited due to neurotoxicity and cross-resistance in mefloquine-resistant Plasmodium falciparum strains.
Topics: Animals; Antimalarials; Calcium; Cells, Cultured; Drug Resistance; Homeostasis; Mefloquine; Microscopy, Confocal; Models, Molecular; Nervous System Diseases; Neurons; Phenanthrenes; Plasmodium falciparum; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Rats | 2004 |
MDR1 gene polymorphisms are associated with neuropsychiatric adverse effects of mefloquine.
Topics: Adult; Aged; Antimalarials; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Confidence Intervals; Cysteine; Female; Gene Frequency; Genes, MDR; Glycine; Haplotypes; Humans; Male; Mefloquine; Mental Disorders; Middle Aged; Nervous System Diseases; Odds Ratio; Organic Anion Transporters; Polymorphism, Genetic; Reference Values; Threonine; Travel; White People | 2006 |
Self-reported adverse events associated with antimalarial chemoprophylaxis in peace corps volunteers.
Topics: Adult; Antimalarials; Doxycycline; Female; Gastrointestinal Diseases; Government Agencies; Hospitalization; Humans; Malaria; Male; Mefloquine; Nervous System Diseases; Patient Compliance; Severity of Illness Index; Skin Diseases; Surveys and Questionnaires; Time Factors; Travel; Volunteers | 2007 |
Mefloquine and scuba diving.
Topics: Antimalarials; Diving; Humans; Malaria, Falciparum; Mefloquine; Nervous System Diseases | 1995 |
Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers.
Topics: Adult; Antimalarials; Chloroquine; Drug Therapy, Combination; Female; Health Surveys; Hospitalization; Humans; Malaria; Male; Mefloquine; Mental Disorders; Nervous System Diseases; Proguanil; Retrospective Studies; Travel; Treatment Refusal; United Kingdom | 1996 |
Neurological sequelae of cerebral malaria.
Topics: Antimalarials; Humans; Malaria, Cerebral; Mefloquine; Nervous System Diseases; Syndrome | 1996 |
Adverse effects and compliance with mefloquine or proguanil antimalarial chemoprophylaxis.
Topics: Adult; Aged; Antimalarials; Female; Gastrointestinal Diseases; Humans; Malaria; Male; Mefloquine; Middle Aged; Nervous System Diseases; Netherlands; Patient Compliance; Proguanil; Reproducibility of Results; Surveys and Questionnaires; Travel; Treatment Refusal | 1997 |
Neuropsychiatric manifestations after mefloquine therapy for Plasmodium falciparum malaria: comparing a retrospective and a prospective study.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Antimalarials; Bias; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Mental Disorders; Nervous System Diseases; Prevalence; Prospective Studies; Research Design; Retrospective Studies; Surveys and Questionnaires | 1998 |
[Mefloquine: neuropsychiatric adverse effects are often severe and persistent long after withdrawal of the drug].
Topics: Adult; Antimalarials; Anxiety Disorders; Female; Humans; Male; Mefloquine; Mental Disorders; Middle Aged; Nervous System Diseases; Sleep Wake Disorders | 1998 |
Neuropsychiatric side effects of mefloquine.
Topics: Humans; Malaria; Mefloquine; Nervous System Diseases; Psychoses, Substance-Induced | 1990 |
Neurologic reactions after a therapeutic dose of mefloquine.
Topics: Humans; Malaria; Mefloquine; Nervous System Diseases | 1989 |